Capital Fund Management (CFM)’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1160 |
|
|
2023
Q4 | – | Sell |
-36,572
| Closed | -$419K | – | 1135 |
|
|
2023
Q3 | $419K | Buy |
36,572
+7,372
| +25% | +$84.6K | ﹤0.01% | 599 |
|
|
2023
Q2 | $739K | Buy |
+29,200
| New | +$739K | ﹤0.01% | 534 |
|
|
2023
Q1 | – | Sell |
-16,900
| Closed | -$312K | – | 934 |
|
|
2022
Q4 | $312K | Buy |
+16,900
| New | +$312K | ﹤0.01% | 510 |
|
|
2020
Q4 | – | Sell |
-13,943
| Closed | -$351K | – | 955 |
|
|
2020
Q3 | $351K | Buy |
+13,943
| New | +$351K | ﹤0.01% | 516 |
|